Literature DB >> 6816295

Calcium-dependent adenylate cyclase of pituitary tumor cells.

M A Brostrom, L A Brotman, C O Brostrom.   

Abstract

Effects of Ca2+ and calmodulin on the adenylate cyclase activity of a prolactin and growth hormone-producing pituitary tumor cell strain (GH3) were examined. The adenylate cyclase activity of homogenates was stimulated approx. 60% by submicromolar free Ca2+ concentrations and inhibited by higher (microM range) concentrations of the cation. A 2-3-fold stimulation of the activity in response to Ca2+ was observed at physiologic concentrations of KCl, with both the stimulatory and inhibitory responses occurring at respectively higher free Ca2+ concentrations. Calmodulin in incubations at low KCl concentrations increased the enzyme activity at all Ca2+ concentrations tested. In incubations conducted at physiologic KCl concentrations, both the inhibitory and stimulatory responses to Ca2+ were shifted by calmodulin to lower respective concentrations of the cation, without significant change occurring in the maximal rate of enzymic activity at optimal free Ca2+ X Mg2+ concentrations in the incubation also influenced the Ca2+ concentration dependence of adenylate cyclase; at high Mg2+ more Ca2+ was required to obtain maximal activity. Trifluoperazine inhibited adenylate cyclase of GH3 cells only in the presence of Ca2+; as Ca2+ concentrations in the assay were increased, higher drug concentrations were required to inhibit the enzyme. Ca2+ was also observed to reduce the extent of enzyme destabilization which occurred during pretreatments at warm temperatures. Vasoactive intestinal polypeptide and phorbol myristate acetate, which stimulate prolactin secretion in intact GH3 cells, enhanced enzyme activity 4- and 2.5-fold, respectively, without added Ca2+. Increasing free Ca2+ concentrations reduced the enhancement by VIP and eliminated the stimulation by PMA.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6816295     DOI: 10.1016/0167-4889(82)90073-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

Review 1.  Calcium, cyclic AMP and protein kinase C--partners in mitogenesis.

Authors:  J F Whitfield; J P Durkin; D J Franks; L P Kleine; L Raptis; R H Rixon; M Sikorska; P R Walker
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

2.  Does calmodulin regulate non-neuronal adenylate cyclase?

Authors:  D M Cooper; K K Caldwell
Journal:  Biochem J       Date:  1988-09-15       Impact factor: 3.857

3.  Cyclic AMP stimulates luteinizing-hormone (lutropin) exocytosis in permeabilized sheep anterior-pituitary cells. Synergism with protein kinase C and calcium.

Authors:  M B Macrae; J S Davidson; R P Millar; P A van der Merwe
Journal:  Biochem J       Date:  1990-11-01       Impact factor: 3.857

4.  Calcium and calmodulin in the regulation of human thyroid adenylate cyclase activity.

Authors:  T Lakey; S Mac Neil; H Humphries; S W Walker; D S Munro; S Tomlinson
Journal:  Biochem J       Date:  1985-02-01       Impact factor: 3.857

5.  Calmodulin activation of adenylate cyclase in the mouse B16 melanoma.

Authors:  S Mac Neil; S W Walker; H J Senior; A Pollock; B L Brown; S S Bleehen; D S Munro; S Tomlinson
Journal:  Biochem J       Date:  1984-12-01       Impact factor: 3.857

6.  Adenosine 3',5'-cyclic monophosphate-dependent release of prolactin from GH3 pituitary tumour cells. A quantitative analysis.

Authors:  S Guild; A H Drummond
Journal:  Biochem J       Date:  1983-12-15       Impact factor: 3.857

7.  Structural basis for inhibition of mammalian adenylyl cyclase by calcium.

Authors:  Tung-Chung Mou; Nanako Masada; Dermot M F Cooper; Stephen R Sprang
Journal:  Biochemistry       Date:  2009-04-21       Impact factor: 3.162

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.